Whole Exome Sequencing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Whole Exome Sequencing Market Report is Segmented by Product (Systems, Kits, and Services), Technology (Second-Generation Sequencing and Third-Generation Sequencing), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Other Applications), and Geography (North America [United States, Canada, and Mexico], Europe [Germany, United Kingdom, France, Italy, Spain, and Rest of Europe], Asia-Pacific [China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific], Middle East and Africa (GCC, South Africa, and Rest of Middle East and Africa], and South America [Brazil, Argentina, and Rest of South America]). The Market Values are Provided in Terms of Value (USD) for the Above Segments.

Whole Exome Sequencing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Whole Exome Sequencing Industry Overview

The whole exome sequencing market is moderately consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of some international and domestic companies that hold market shares and are well known, including Eurofins Scientific Group, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, illumine Inc., and Thermo Fisher Scientific Inc. Konica Minolta Inc. (Ambry Genetics), Beijing Genomics Institute, Azenta Inc., Psomagen Inc. (Macrogen Inc.), PerkinElmer Inc., GENEYX GENOMEX, and CD Genomics, QIAGEN Inc.

Whole Exome Sequencing Market Leaders

  1. Bio-Rad Laboratories Inc.

  2. Eurofins Scientific Group

  3. F. Hoffmann-La Roche AG

  4. Illumina Inc.

  5. Thermo Fisher Scientific Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Whole Exome Sequencing Market Concentration